Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Bank Multiarta Sentosa Tbk. (MASB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Bank Multiarta Sentosa Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp232 (market cap 316.25B, 41.7K 24h volume), while Bank Multiarta Sentosa Tbk. trades at Rp3,390 (market cap 4.58T, 8.1K 24h volume). The key difference: Bank Multiarta Sentosa Tbk. is far larger — about 14.5× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (41.7K versus 8.1K). Which is the better fit depends on your goals.
| DGNS | MASB | |
|---|---|---|
Market Cap | 316.25B | 4.58T |
Volume | 41.7K | 8.1K |
Lot | 417 | 81 |
Turnover | 9.66M | 27.31M |
Average Price | 231.65 | 3,371.85 |
Value | 9.66M | 27.31M |
Indicative Equilibrium Price | 230 | 3,390 |
Indicative Equilibrium Volume | 2.4K | 10 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Bank Multiarta Sentosa Tbk.
PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Read more on MASB →
